Neonatal screening for sickle cell disorders: what about the carrier infants?
about
Disclosing to parents newborn carrier status identified by routine blood spot screeningImparting carrier status results detected by universal newborn screening for sickle cell and cystic fibrosis in England: a qualitative study of current practice and policy challenges.Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.Ethical issues in DNA testing.Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.Genetic screening.Ethnicity and the politics of the new genetics: principles and engagement.Neonatal screening for sickle cell disorders.Factors that influence parents' experiences with results disclosure after newborn screening identifies genetic carrier status for cystic fibrosis or sickle cell hemoglobinopathySickle Cell Trait from a Metabolic, Renal, and Vascular Perspective: Linking History, Knowledge, and Health.Parents' responses to receiving sickle cell or cystic fibrosis carrier results for their child following newborn screeningParents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era.A systematic review of the effects of disclosing carrier results generated through newborn screening.Effort required to contact primary care providers after newborn screening identifies sickle cell trait.Infants in Sandwell are screened for haemoglobinopathy gene.Genetic counseling following the detection of hemoglobinopathy trait on the newborn screen is well received, improves knowledge, and relieves anxiety.Genetic profiling of newborns: ethical and social issues.Informing children of their newborn screening carrier result for sickle cell or cystic fibrosis: qualitative study of parents' intentions, views and support needs.Benefits and burdens of newborn screening: public understanding and decision-makingQuestioning the consensus: managing carrier status results generated by newborn screening
P2860
Q24245906-7140E3BB-68DC-475E-B91F-69EAA50CED16Q33310203-92046312-3A92-45B5-8A5B-CB200F6ABD52Q33315119-6D430C26-A5C6-406E-8A77-4E5296CE056AQ33334959-2A9894A8-02FF-4F61-8C8C-EBFC528FEF2DQ34329302-E0364386-0FD4-453F-A3D0-D3B563DAD17DQ35193941-44857C49-6DF4-4BF9-AE63-90C14E742D5CQ35606394-7496D253-903C-460D-8E1F-6F4DFE831E64Q35626383-FD7BDC9B-6B6E-48BB-8753-93F392606EFAQ35894760-3D5A8563-69E7-4529-B1F6-CE2624DB9968Q35994946-34DC959E-9030-443C-B6D8-60E220D7D6B4Q36338172-FB6622AF-B1C0-423F-BD81-7E987359F4F0Q36474043-BF464891-0DB4-4C82-B3C7-59CB9E4280F9Q37310235-7F633D7A-4C26-42BF-9DC6-F2F8BAF894A4Q37433370-2B74CC7F-748F-4F40-A41F-8C0C1DCDBC6EQ43190980-428F8B39-AE7C-4576-B4C8-A925F21605B6Q48677907-40E96896-2483-40ED-8924-3493F9A89055Q53264827-E9669403-F7F8-4C4F-A92E-454864DDF5DFQ54489357-E4B22D7E-81F1-4F32-A1D6-447BDBA0D6ACQ57519269-7441EC33-F1BD-45C7-87BD-C908C7A6B955Q57768923-4136909B-1071-49CA-87D2-A5CE973C0F07
P2860
Neonatal screening for sickle cell disorders: what about the carrier infants?
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Neonatal screening for sickle cell disorders: what about the carrier infants?
@ast
Neonatal screening for sickle cell disorders: what about the carrier infants?
@en
type
label
Neonatal screening for sickle cell disorders: what about the carrier infants?
@ast
Neonatal screening for sickle cell disorders: what about the carrier infants?
@en
prefLabel
Neonatal screening for sickle cell disorders: what about the carrier infants?
@ast
Neonatal screening for sickle cell disorders: what about the carrier infants?
@en
P2860
P356
P1433
P1476
Neonatal screening for sickle cell disorders: what about the carrier infants?
@en
P2093
P2860
P304
P356
10.1136/BMJ.313.7054.407
P407
P577
1996-08-01T00:00:00Z